Name | PF 05175157 |
Synonyms | CS-2573 PF05175157 PF 05175157 PF-05175157 1-isopropyl-1'-(2-methyl-1H-benzo[d]imidazole-5-carbonyl)-4,6-dihydrospiro[indazole-5,4'-piperidin]-7(1H)-one 1'-(2-methyl-1H-1,3-benzodiazole-6-carbonyl)-1-(propan-2-yl)-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidin]-7-one 1,4-Dihydro-1'-[2-methyl-1H-benzimidazol-6-yl)carbonyl]-1-(1-methylethyl)-spiro[5H-indazole-5,4'-piperidin]-7(6H)-one Spiro[5H-indazole-5,4'-piperidin]-7(6H)-one,1,4-dihydro-1'-[(2-methyl-1H-benzimidazol-6-yl)carbonyl]-1-(1-methylethyl)- |
CAS | 1301214-47-0 |
Molecular Formula | C23H27N5O2 |
Molar Mass | 405.49 |
Density | 1.38±0.1 g/cm3(Predicted) |
Boling Point | 692.0±55.0 °C(Predicted) |
pKa | 11.47±0.10(Predicted) |
Storage Condition | -20℃ |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.466 ml | 12.331 ml | 24.662 ml |
5 mM | 0.493 ml | 2.466 ml | 4.932 ml |
10 mM | 0.247 ml | 1.233 ml | 2.466 ml |
5 mM | 0.049 ml | 0.247 ml | 0.493 ml |
biological activity | PF-05175157 is a broad-spectrum effective ACC inhibitor for human ACC1, human ACC2, the IC50 of rat ACC1 and rat ACC2 were 27.0 nM, 33.0 nM, 23.5 nM and 50.4 nM, respectively. |
Target | Value |
rACC1 (Cell-free assay) | 23.5 nM |
hACC1 (Cell-free assay) | 27.0 nM |
hACC2 (Cell-free assay) | 33.0 nM |
rACC2 (Cell-free assay) | 50.4 nM |